Clinical Trial

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer screening CT participation at 6 months after the baseline outpatient visit? The intervention is an alert to the provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool. Intervention and non-intervention arms will be compared to determine if lung cancer screening CT participation increases. Individuals who are considered high-risk by the tool, but who do not meet the Medicare/USPSTF pack-year or quit-date lung screening eligibility criteria may be offered research lung screening CT.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-28; most recent amendment 2026-05-06.
Status change: Not Yet Recruiting → Recruiting 2025-06-05
Trial Details
NCT Number NCT06910956
Lead Sponsor Massachusetts General Hospital
Collaborators: Harvard Risk Management Foundation
Conditions Lung Cancer, Health Screening, Early Cancer Detection, Deep Learning
Enrollment 1,500 participants
Start Date 2025-05-20
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-11